Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials.

Coronary artery disease Meta-analysis Modified balloons Stent

Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
06 Nov 2023
Historique:
received: 08 07 2023
accepted: 12 10 2023
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: aheadofprint

Résumé

The performance of modified balloons (namely cutting or scoring balloons) to prepare severely calcified lesions in patients undergoing percutaneous coronary intervention (PCI) remains controversial. We investigated the clinical and imaging outcomes of patients undergoing PCI assigned to modified balloon therapy to prepare severely calcified coronary lesions before stent implantation. In this meta-analysis, we aggregated the study-level data from trials enrolling invasively treated patients who were randomly assigned to modified balloon or control therapy to prepare severely calcified lesions before stenting. The primary outcome was major adverse cardiac events (MACE), including death, myocardial infarction (MI), and repeat revascularization. The secondary outcomes included the individual components of the primary outcome, coronary perforation and final minimal stent area (MSA) as measured by intracoronary imaging. A total of 648 participants in six trials were allocated to modified balloon therapy (n = 335) or control therapy (semi-compliant, non-compliant, or super high-pressure balloon, n = 313). The median follow-up was 11 months. Overall, MACE occurred in 8.96% of patients assigned to a modified balloon and 12.78% of patients assigned to control therapy [risk ratio = 0.70, 95% confidence interval (CI) 0.35-1.39; P = 0.24]. There was a significant treatment effect-by-modified balloon type interaction for the outcome MACE in patients assigned to cutting balloon compared with control therapy [RR = 0.40 (0.28-0.56), P for interaction (P In patients treated with PCI for severely calcific coronary artery disease a strategy of lesion preparation with a modified balloon before stenting does not improve clinical or imaging outcomes compared with control therapy. The different performance of cutting and scoring balloons warrants further investigation.

Sections du résumé

BACKGROUND BACKGROUND
The performance of modified balloons (namely cutting or scoring balloons) to prepare severely calcified lesions in patients undergoing percutaneous coronary intervention (PCI) remains controversial. We investigated the clinical and imaging outcomes of patients undergoing PCI assigned to modified balloon therapy to prepare severely calcified coronary lesions before stent implantation.
METHODS METHODS
In this meta-analysis, we aggregated the study-level data from trials enrolling invasively treated patients who were randomly assigned to modified balloon or control therapy to prepare severely calcified lesions before stenting. The primary outcome was major adverse cardiac events (MACE), including death, myocardial infarction (MI), and repeat revascularization. The secondary outcomes included the individual components of the primary outcome, coronary perforation and final minimal stent area (MSA) as measured by intracoronary imaging.
RESULTS RESULTS
A total of 648 participants in six trials were allocated to modified balloon therapy (n = 335) or control therapy (semi-compliant, non-compliant, or super high-pressure balloon, n = 313). The median follow-up was 11 months. Overall, MACE occurred in 8.96% of patients assigned to a modified balloon and 12.78% of patients assigned to control therapy [risk ratio = 0.70, 95% confidence interval (CI) 0.35-1.39; P = 0.24]. There was a significant treatment effect-by-modified balloon type interaction for the outcome MACE in patients assigned to cutting balloon compared with control therapy [RR = 0.40 (0.28-0.56), P for interaction (P
CONCLUSIONS CONCLUSIONS
In patients treated with PCI for severely calcific coronary artery disease a strategy of lesion preparation with a modified balloon before stenting does not improve clinical or imaging outcomes compared with control therapy. The different performance of cutting and scoring balloons warrants further investigation.

Identifiants

pubmed: 37930402
doi: 10.1007/s00392-023-02324-y
pii: 10.1007/s00392-023-02324-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s).

Références

Shah M, Najam O, Bhindi R et al (2021) Calcium modification techniques in complex percutaneous coronary intervention. Circ Cardiovasc Interv 14:e009870
doi: 10.1161/CIRCINTERVENTIONS.120.009870 pubmed: 33441017
Guedeney P, Claessen BE, Mehran R et al (2020) Coronary calcification and long-term outcomes according to drug-eluting stent generation. JACC Cardiovasc Interv 13:1417–1428
doi: 10.1016/j.jcin.2020.03.053 pubmed: 32553329
Redfors B, Maehara A, Witzenbichler B et al (2017) Outcomes after successful percutaneous coronary intervention of calcified lesions using rotational atherectomy, cutting-balloon angioplasty, or balloon-only angioplasty before drug-eluting stent implantation. J Invasive Cardiol 29:378–386
pubmed: 28623669
De Maria GL, Scarsini R, Banning AP (2019) Management of calcific coronary artery lesions: is it time to change our interventional therapeutic approach? JACC Cardiovasc Interv 12:1465–1478
pubmed: 31395217
Rheude T, Fitzgerald S, Allali A et al (2022) Rotational atherectomy or balloon-based techniques to prepare severely calcified coronary lesions. JACC Cardiovasc Interv 15:1864–1874
doi: 10.1016/j.jcin.2022.07.034 pubmed: 36137691
Tang Z, Bai J, Su SP et al (2014) Cutting-balloon angioplasty before drug-eluting stent implantation for the treatment of severely calcified coronary lesions. J Geriatr Cardiol 11:44–49
pubmed: 24748881 pmcid: 3981983
Sterne JAC, Savovic J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898
doi: 10.1136/bmj.l4898 pubmed: 31462531
Juni P, Witschi A, Bloch R et al (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA J Am Med Assoc 282:1054–1060
doi: 10.1001/jama.282.11.1054
Higgins JP, Altman DG, Gotzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
doi: 10.1136/bmj.d5928 pubmed: 22008217 pmcid: 3196245
IntHout J, Ioannidis JP, Rovers MM et al (2016) Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 6:e010247
doi: 10.1136/bmjopen-2015-010247 pubmed: 27406637 pmcid: 4947751
Rücker G (2012) Network meta-analysis, electrical networks and graph theory. Res Syn Methods 3:312–324
doi: 10.1002/jrsm.1058
Turner RM, Bird SM, Higgins JP (2013) The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS ONE 8:e59202
doi: 10.1371/journal.pone.0059202 pubmed: 23544056 pmcid: 3609745
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924
Li Q, He Y, Chen L et al (2016) Intensive plaque modification with rotational atherectomy and cutting balloon before drug-eluting stent implantation for patients with severely calcified coronary lesions: a pilot clinical study. BMC Cardiovasc Disord 16:112
doi: 10.1186/s12872-016-0273-8 pubmed: 27230875 pmcid: 4882826
Abdel-Wahab M, Toelg R, Byrne RA et al (2018) High-speed rotational atherectomy versus modified balloons prior to drug-eluting stent implantation in severely calcified coronary lesions. Circ Cardiovasc Interv 11:e007415
doi: 10.1161/CIRCINTERVENTIONS.118.007415 pubmed: 30354632
Rheude T, Rai H, Richardt G et al (2021) Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial. EuroIntervention 17:481–488
doi: 10.4244/EIJ-D-20-01000 pubmed: 33258774 pmcid: 9724952
Han F, Zheng H, Zheng X et al (2021) Efficacy of intravascular ultrasound-guided rotational atherectomy combined with cutting balloon for pretreatment of severe coronary artery calcified lesions. Nan Fang Yi Ke Da Xue Xue Bao 41:1044–1049
pubmed: 34308854
Mangieri A, Nerla R, Castriota F et al (2023) Cutting balloon to optimize predilation for stent implantation: the COPS randomized trial. Catheter Cardiovasc Interv 101:798–805
doi: 10.1002/ccd.30603 pubmed: 36841945
Kinoshita Y, Iwasaki K, Suzuki T (2022) Verification of the differences of scoring effect in current scoring balloons. Cardiovasc Interv Ther 37:513–518
doi: 10.1007/s12928-021-00807-1 pubmed: 34432207
Angsubhakorn N, Kang N, Fearon C et al (2022) Contemporary management of severely calcified coronary lesions. J Pers Med 12:1638
doi: 10.3390/jpm12101638 pubmed: 36294777 pmcid: 9605395
Matsukawa R, Kozai T, Tokutome M et al (2019) Plaque modification using a cutting balloon is more effective for stenting of heavily calcified lesion than other scoring balloons. Cardiovasc Interv Ther 34:325–334
doi: 10.1007/s12928-019-00578-w pubmed: 30771163
Fujimura T, Matsumura M, Witzenbichler B et al (2021) Stent expansion indexes to predict clinical outcomes: an IVUS substudy from ADAPT-DES. JACC Cardiovasc Interv 14:1639–1650
doi: 10.1016/j.jcin.2021.05.019 pubmed: 34353595
Allali A, Toelg R, Abdel-Wahab M et al (2022) Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: the PREPARE-CALC-COMBO study. Catheter Cardiovasc Interv 100:979
doi: 10.1002/ccd.30423 pubmed: 36262074
Allali A, Abdel-Wahab M, Elbasha K et al (2022) Rotational atherectomy of calcified coronary lesions: current practice and insights from two randomized trials. Clin Res Cardiol 112:1143
doi: 10.1007/s00392-022-02013-2 pubmed: 35482101 pmcid: 10450020
Patel N, Bandyopadhyay D, Agarwal G et al (2022) Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: a meta-analysis. Catheter Cardiovasc Interv 99:1741–1749
doi: 10.1002/ccd.30159 pubmed: 35366389
Mankerious N, Hemetsberger R, Traboulsi H et al (2021) Outcomes of patients treated with a biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stents after rotational atherectomy. Clin Res Cardiol 110:1574–1585
doi: 10.1007/s00392-021-01852-9 pubmed: 33861369
Wang X, Matsumura M, Mintz GS et al (2017) In vivo calcium detection by comparing optical coherence tomography, intravascular ultrasound, and angiography. JACC Cardiovasc Imaging 10:869–879
doi: 10.1016/j.jcmg.2017.05.014 pubmed: 28797408

Auteurs

Maria Scalamogna (M)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.
Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

Constantin Kuna (C)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Felix Voll (F)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Alp Aytekin (A)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Shqipdona Lahu (S)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Thorsten Kessler (T)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Sebastian Kufner (S)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Tobias Rheude (T)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Hendrik B Sager (HB)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Erion Xhepa (E)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Jens Wiebe (J)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Michael Joner (M)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Gjin Ndrepepa (G)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.

Adnan Kastrati (A)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.

Salvatore Cassese (S)

Klinik Für Herz- Und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Lazarettstrasse, 36, Munich, Germany. cassese@dhm.mhn.de.

Classifications MeSH